Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Phase 2 symbols : Otic save search
Otonomy Reports Results from Phase 2 Clinical Trial of OTO-313 in Patients with Tinnitus
Published: 2022-08-01 (Crawled : 12:00) - biospace.com/
OTIC | $0.077
|
Health Technology
|
| O: -74.57%
H: 16.16%
C: -21.27%
oto-313 trial results phase 2
Otonomy Completes Enrollment in Phase 2 Clinical Trial of OTO-313 in Tinnitus
Published: 2022-02-22 (Crawled : 13:30) - biospace.com/
OTIC | $0.077
|
Health Technology
|
| O: 1.5%
H: 3.77%
C: -0.49%
oto-313 phase 2 trial enroll
Otonomy Announces Publication of Phase 1/2 Trial Results Showing Tinnitus Improvement in Patients Receiving OTO-313
Published: 2021-10-12 (Crawled : 12:00) - globenewswire.com
OTIC | $0.077
|
Health Technology
|
| O: 0.0%
H: 3.45%
C: 0.0%
phase 1 results trial trial results phase 2
AGTC Reports 12-Month Data from its Ongoing Phase 1/2 Achromatopsia Clinical Trials Showing Biologic Activity in Patients with Mutations in the ACHM B3 Gene
Published: 2021-06-24 (Crawled : 12:00) - biospace.com/
OTIC | $0.077
|
Health Technology
|
| O: -0.89%
H: 3.14%
C: 1.35%
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 5.28%
H: 4.56%
C: -1.59%
ongoing clinical trials phase 1 trial phase 2
AGTC to Host Conference Call to Discuss Achromatopsia 12-Month Data in its Ongoing Phase 1/2 Clinical Trials
Published: 2021-06-23 (Crawled : 21:00) - agtc.com
OTIC | $0.077
|
Health Technology
|
| O: -0.89%
H: 3.14%
C: 1.35%
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 5.28%
H: 4.56%
C: -1.59%
ongoing clinical trials phase 1 trial conference phase 2 phase 3
Otonomy Initiates Expansion of Phase 1/2 Clinical Trial for OTO-413 in Hearing Loss
Published: 2021-06-15 (Crawled : 12:00) - globenewswire.com
OTIC | $0.077
|
Health Technology
|
| O: 2.13%
H: 2.92%
C: -1.67%
phase 1 expansion trial hearing loss phase 3 phase 2
Otonomy Initiates Phase 2 Clinical Trial of OTO-313 in Tinnitus
Published: 2021-03-25 (Crawled : 13:00) - biospace.com/
OTIC | $0.077
|
Health Technology
|
| O: -1.88%
H: 2.3%
C: 0.0%
phase 2 trial
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.